Publications

Journal Article
Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't
Epublish 84 citations
Electronic publication date
June 16, 2012

View on Pubmed.gov 22185458 | View on doi.org 10.1186/1750-13...

Microglial p38α MAPK is critical for LPS-induced neuron degeneration, through a mechanism involving TNFα.

Search for publications in this journal Mol Neurodegener

Abstract

BACKGROUND

The p38α MAPK isoform is a well-established therapeutic target in peripheral inflammatory diseases, but the importance of this kinase in pathological microglial activation and detrimental inflammation in CNS disorders is less well understood. To test the role of the p38α MAPK isoform in microglia-dependent neuron damage, we used primary microglia from wild-type (WT) or p38α MAPK conditional knockout (KO) mice in co-culture with WT cortical neurons, and measured neuron damage after LPS insult.

RESULTS

We found that neurons in co-culture with p38α-deficient microglia were protected against LPS-induced synaptic loss, neurite degeneration, and neuronal death. The involvement of the proinflammatory cytokine TNFα was demonstrated by the findings that p38α KO microglia produced much less TNFα in response to LPS compared to WT microglia, that adding back TNFα to KO microglia/neuron co-cultures increased the LPS-induced neuron damage, and that neutralization of TNFα in WT microglia/neuron co-cultures prevented the neuron damage. These results using cell-selective, isoform-specific KO mice demonstrate that the p38α MAPK isoform in microglia is a key mediator of LPS-induced neuronal and synaptic dysfunction. The findings also provide evidence that a major mechanism by which LPS activation of microglia p38α MAPK signaling leads to neuron damage is through up-regulation of the proinflammatory cytokine TNFα.

CONCLUSIONS

The data suggest that selective targeting of p38α MAPK signaling should be explored as a potential therapeutic strategy for CNS disorders where overproduction of proinflammatory cytokines is implicated in disease progression.

References

Injury. 2007 Dec;38(12):1392-400

Physiol Rev. 2011 Apr;91(2):461-553

J Neurochem. 1999 May;72(5):2053-8

Exp Neurol. 2003 Oct;183(2):394-405

Cited by 84 citations (total)

Journal Article

KMS99220 Exerts Anti-Inflammatory Effects, Activates the Nrf2 Signaling and Interferes with IKK, JNK and p38 MAPK via HO-1.

Electronic publication date January 28, 2020

Search for publications in this journal Mol Cells

Ji Ae Lee [...] Onyou Hwang et al.

Neuroinflammation is an important contributor to the pathogenesis of neurodegenerative disorders including Parkinson's disease (PD). We previously reported that our...

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

An isoform-selective p38α mitogen-activated protein kinase inhibitor rescues early entorhinal cortex dysfunctions in a mouse model of Alzheimer's disease.

Electronic publication date September 29, 2019

Search for publications in this journal Neurobiol Aging

Grazia Rutigliano [...] Nicola Origlia et al.

Neuroinflammation is a fundamental mechanism in Alzheimer's disease (AD) progression. The stress-induced activation of the p38α mitogen-activated protein kinase (MAPK)...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances